Successful treatment of infliximab in a patient with scleroderma: a case report

RATIONALE: Systemic Scleroderma (SSc) is a rare connective tissue disease clinically characterized by cutaneous sclerosis and variable systemic involvement. No drug is currently available to effectively reverse the fibrotic process in SSc. Previous reports have suggested that the tumor necrosis fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Liu, Yaoyang, Xu, Huji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459692/
https://www.ncbi.nlm.nih.gov/pubmed/28562527
http://dx.doi.org/10.1097/MD.0000000000006737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459692/
https://www.ncbi.nlm.nih.gov/pubmed/28562527
http://dx.doi.org/10.1097/MD.0000000000006737

Ejemplares similares